The Safety, Tolerability and Pharmacokinetics of BI 409306, a Novel and Potent PDE9 Inhibitor: Overview of Three Phase I Randomised Trials in Healthy Volunteers
European neuropsychopharmacology（2018）
关键词
Phase I,Healthy volunteers,pharrnacokinetics,Phosphodiesterase inhibitors,Safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要